← Leaderboards
Mark W. Majesky
University Of Virginia Charlottesville
$11,012,717
Attributed
$15,043,034
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,043,034 · 6
By mechanism
R01$9,910,735 · 4
T32$3,223,245 · 1
P01$1,909,054 · 1
Top collaborators
- Mary Cm Weiser-Evans7 shared
- Stephen Mark Schwartz6 shared
Most similar at University Of Virginia Charlottesville
Same institution · by research overlap
- Frederick H. Epstein$8,903,632
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseMolecularCellsPathway InteractionsStem CellsSignal TransductionTunica AdventitiaRepairedAdultProteinsTissuesBlood VesselsStemGrowthPericytesPlayGeneticReporterIn VitroProgenitorGenesArteriesSmoothened Signaling PathwayEmbryo
Grant awards (29)
Reprogramming of mature SMCs to vascular progenitor cells: Focus on Vascular Fibrosis$758,147
R01 · FY2025 · HL
Reprogramming of mature SMCs to vascular progenitor cells: Focus on Vascular Fibrosis$742,984
R01 · FY2024 · HL
Reprogramming of mature SMCs to vascular progenitor cells: Focus on Vascular Fibrosis$772,147
R01 · FY2023 · HL
Reprogramming of mature smooth muscle cells to vascular progenitor cells$637,559
R01 · FY2022 · HL
Reprogramming of mature smooth muscle cells to vascular progenitor cells$637,559
R01 · FY2021 · HL
Reprogramming of mature smooth muscle cells to vascular progenitor cells$637,559
R01 · FY2020 · HL
Acomys cahrinus: a new paradigm for kidney wound repair$282,450
R01 · FY2020 · DK · contact PI
Reprogramming of mature smooth muscle cells to vascular progenitor cells$651,434
R01 · FY2019 · HL
Experimental Pathology of Cardiovascular Disease$411,956
T32 · FY2019 · HL · contact PI
Acomys cahrinus: a new paradigm for kidney wound repair$282,450
R01 · FY2019 · DK · contact PI
Experimental Pathology of Cardiovascular Disease$724,917
T32 · FY2018 · HL
Acomys cahrinus: a new paradigm for kidney wound repair$282,450
R01 · FY2018 · DK · contact PI
Experimental Pathology of Cardiovascular Disease$706,808
T32 · FY2017 · HL
Resident Progenitor Cells in the Adventitia$509,799
R01 · FY2017 · HL · contact PI
Experimental Pathology of Cardiovascular Disease$7,541
T32 · FY2017 · HL
Experimental Pathology of Cardiovascular Disease$694,820
T32 · FY2016 · HL
Resident Progenitor Cells in the Adventitia$626,424
R01 · FY2016 · HL · contact PI
Experimental Pathology of Cardiovascular Disease$677,203
T32 · FY2015 · HL
Resident Progenitor Cells in the Adventitia$617,028
R01 · FY2015 · HL · contact PI
Resident Progenitor Cells in the Adventitia$649,549
R01 · FY2014 · HL · contact PI
Hedgehog Signaling in the Adventitia$482,625
R01 · FY2012 · HL · contact PI
Hedgehog Signaling in the Adventitia$487,500
R01 · FY2011 · HL · contact PI
Hedgehog Signaling in the Adventitia$487,500
R01 · FY2010 · HL · contact PI
Development of Coronary Smooth Muscle$402,017
P01 · FY2009 · HL · contact PI
Hedgehog Signaling in the Adventitia$365,571
R01 · FY2009 · HL · contact PI
Development of Coronary Smooth Muscle$382,558
P01 · FY2008 · HL · contact PI
Development of Coronary Smooth Muscle$379,060
P01 · FY2007 · HL · contact PI
Development of Coronary Smooth Muscle$366,181
P01 · FY2006 · HL · contact PI
Development of Coronary Smooth Muscle$379,238
P01 · FY2005 · HL